Copyright
©The Author(s) 2019.
World J Gastroenterol. May 7, 2019; 25(17): 2133-2143
Published online May 7, 2019. doi: 10.3748/wjg.v25.i17.2133
Published online May 7, 2019. doi: 10.3748/wjg.v25.i17.2133
Patient | Nutricion | Somatostatin | Dosage | Interval | Loperamide1 | Disease | NET type | Primary | Metastases | in | PRRT | |||
consultation | analog | stage | Liver | Lymph | Bone | Lung | Peritoneum | |||||||
1 | yes | OCT | 30 mg | 4 wk | if required | IV | functional | midgut | x | x | x | 2nd | ||
2 | yes | OCT | 20 mg | 4 wk | if required | IIIb | functional | midgut | x | x | x | 3rd | ||
3 | yes | OCT | 30 mg | 4 wk | no | IV | functional | midgut | x | x | x | x | 2nd | |
4 | yes | LAN | 120 mg | 6 wk | no | IV | functional | midgut | x | x | x | x | 2nd | |
5 | yes | LAN | 120 mg | 3 wk | no | IV | functional | midgut | x | x | 2nd | |||
6 | yes | OCT | 30 mg | 4 wk | no | IIIb | functional | midgut | x | x | 4th | |||
7 | yes | OCT | 30 mg | 4 wk | no | IIIb | functional | midgut | x | x | 3rd | |||
8 | yes | LAN | 120 mg | 4 wk | if required | IV | functional | midgut | x | x | 2nd | |||
9 | yes | no | no | IV | nonfunctional | pancreas | x | x | x | 1st | ||||
10 | yes | OCT | 30 mg | 4 wk | no | IV | functional | midgut | x | x | x | 3rd | ||
OCT s.c. | + 100 µg | if required | ||||||||||||
11 | yes | OCT | 30 mg | 4 wk | no | IIIb | functional | midgut | x | x | 1st | |||
12 | yes | LAN | 120 mg | 4 wk | if required | IV | functional | midgut | x | 2nd | ||||
13 | yes | OCT | 30 mg | 4 wk | if required | IV | functional | midgut | x | 3rd | ||||
14 | yes | LAN | 120 mg | 4 wk | no | IV | functional | appendix | x | 2nd | ||||
15 | yes | OCT | 30 mg | 4 wk | no | IV | functional | midgut | x | x | x | 3rd | ||
16 | yes | OCT | 20 mg | 4 wk | if required | IV | functional | midgut | x | x | 2nd | |||
17 | yes | LAN | 120 mg | 4 wk | if required | IIIb | functional | midgut | x | x | x | 2nd | ||
18 | yes | OCT | 30 mg | 3 wk | if required | IV | functional | CUP | x | x | 3rd | |||
19 | yes | OCT | 30 mg | 4 wk | no | IV | nonfunctional | pancreas | x | x | x | 1st | ||
20 | yes | OCT | 30 mg | 4 wk | no | IV | functional | CUP | x | x | 3rd |
- Citation: Langbein T, Dathe W, Deuerling A, Baum RP. Efficacy of Detoxsan® powder on diarrhea caused by gastrointestinal neuroendocrine tumors. World J Gastroenterol 2019; 25(17): 2133-2143
- URL: https://www.wjgnet.com/1007-9327/full/v25/i17/2133.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i17.2133